rs10889335
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001367561.1(DOCK7):c.5062T>C(p.Leu1688=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.349 in 1,611,696 control chromosomes in the GnomAD database, including 100,413 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L1688L) has been classified as Likely benign.
Frequency
Consequence
NM_001367561.1 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DOCK7 | NM_001367561.1 | c.5062T>C | p.Leu1688= | synonymous_variant | 40/50 | ENST00000635253.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DOCK7 | ENST00000635253.2 | c.5062T>C | p.Leu1688= | synonymous_variant | 40/50 | 5 | NM_001367561.1 |
Frequencies
GnomAD3 genomes AF: 0.347 AC: 52728AN: 151932Hom.: 9332 Cov.: 32
GnomAD3 exomes AF: 0.343 AC: 86169AN: 250866Hom.: 15615 AF XY: 0.346 AC XY: 46840AN XY: 135550
GnomAD4 exome AF: 0.349 AC: 509403AN: 1459646Hom.: 91072 Cov.: 36 AF XY: 0.351 AC XY: 254964AN XY: 725840
GnomAD4 genome AF: 0.347 AC: 52768AN: 152050Hom.: 9341 Cov.: 32 AF XY: 0.346 AC XY: 25689AN XY: 74302
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 20, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 14, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Developmental and epileptic encephalopathy, 23 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 15, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 58% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 54. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at